← Open Payments lookup

MARK RONCONE: Open Payments

NPI 1669982872 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$564 in 37 payments from 10 companies in 2025. Trend: 2023 $419 · 2024 $662 · 2025 $564

Food & beverage: $564
CompanyPaymentsAmount
ABBVIE INC.20$217
Novo Nordisk Inc5$100
Axsome Therapeutics, Inc.3$64
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$57
Otsuka America Pharmaceutical, Inc.1$29
AstraZeneca Pharmaceuticals LP1$22
Cranial Technologies, Inc1$20
GlaxoSmithKline, LLC.1$20
Vanda Pharmaceuticals Inc.1$18
Lilly USA, LLC1$17

Products named: VRAYLAR, QULIPTA, Ozempic, Auvelity, CAPLYTA, ABILIFY MAINTENA, AIRSUPRA, Doc Band.

Industry payments across MD — which companies pay providers there.